| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/06/2004 | US6673365 Administering hooc-ch2-(r)-cgl-aze-pab where cgl is cyclohexylglycine, aze is azetidine-2-carboxylic acid, and pab is 1-amidino-4-aminomethylbenzene |
| 01/06/2004 | US6673363 Transdermal and topical administration of local anesthetic agents using basic enhancers |
| 01/06/2004 | US6673356 Compounds and methods for the diagnosis and treatment of ehrlichia infection |
| 01/06/2004 | US6673355 Administering vaccine to pregnant women; prevention and diagnosis of gastroenteritis, cystic fibrosis, and diarrhea |
| 01/06/2004 | US6673354 Compositions and methods for treating papillomavirus-infected cells |
| 01/06/2004 | US6673353 Tuberculosis vaccine |
| 01/06/2004 | US6673352 Use of Mullerian inhibiting substance for treating excess androgen states |
| 01/06/2004 | US6673351 Immunotherapeutic agent comprising purified protein extract derived from killed cells of amastigotes and leishmania |
| 01/06/2004 | US6673350 Argleuleugluphetyrleualamet nonapeptide and t lymphocyte cell sample from melanoma subject; reacts with major histocompatibility complex; cancer, autoimmune disease, and infection diagnosis |
| 01/06/2004 | US6673348 Heat shock protein-based vaccines and immunotherapies |
| 01/06/2004 | US6673347 Conjugated to polymer via schiff base, hydrazone, oxime, or azomethine compound; diagnosing tumors and metastasis |
| 01/06/2004 | US6673344 Antibodies to human CKβ-10/MCP-4 |
| 01/06/2004 | US6673343 Useful for activating their respective receptor and thereby enabling the role of tyrosine kinase receptor in cell growth and/or differentiation to be studied |
| 01/06/2004 | US6673342 Administering dimeric or polymeric iga antibodies that are for useful in preventing or inhibiting infection by pathogens |
| 01/06/2004 | US6673341 Inhibiting transforming growth factor (tgf-beta) mediated angiogenesis, thereby inhibiting the proliferative disease in vertebrate |
| 01/06/2004 | US6673335 Compositions and methods for the pulmonary delivery of aerosolized medicaments |
| 01/06/2004 | US6673039 Compositions, kits, methods, and apparatus for transvascular delivery of a composition to an extravascular tissue of a mammal |
| 01/06/2004 | CA2135083C Antibodies to p-selectin and their uses |
| 01/06/2004 | CA2134094C Production of recombinant human lactoferrin |
| 01/06/2004 | CA2128208C Novel seven transmembrane receptors |
| 01/06/2004 | CA2096109C Tissue factor based prothrombin time reagent |
| 01/06/2004 | CA2086681C Growth promoting agent derived from milk |
| 01/06/2004 | CA2047721C Use of intercellular adhesion molecules, and their binding ligands in the treatment of asthma |
| 01/02/2004 | EP1375665A1 Lysomomal enzyme composition |
| 01/02/2004 | EP1375663A1 Novel protein, dna thereof and use of the same |
| 01/02/2004 | EP1375662A1 A novel polypeptide compose substance for promoting blood and blood vessel cell growth |
| 01/02/2004 | EP1375661A1 The role of the N-myc - nm23H1/nm23H2 - cdc42 pathway in proliferation, differentiation and treatment of cancer |
| 01/02/2004 | EP1375520A1 Apoptosis induced by monoclonal antibody anti-Her2 |
| 01/02/2004 | EP1375517A1 Structure of a glucocorticoid receptor ligand binding domain comprising an expanded binding pocket and methods employing same |
| 01/02/2004 | EP1375516A2 Method of production of a recombinant polypeptide of the LSR receptor |
| 01/02/2004 | EP1375515A2 Polypeptide, cDNA encoding the same, and use thereof |
| 01/02/2004 | EP1375513A1 Immunopotentiators |
| 01/02/2004 | EP1375511A2 Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus |
| 01/02/2004 | EP1375510A1 Modification of collagenous materials and medical treatment, diagnosis and monitoring of fibrotic conditions |
| 01/02/2004 | EP1374908A2 Polymer-drug conjugates comprising hydrazide linkers |
| 01/02/2004 | EP1374902A1 Remedies for inflammatory bowel diseases |
| 01/02/2004 | EP1374901A1 Graft rejection suppressors |
| 01/02/2004 | EP1374899A1 Remedies for post-traumatic stress disorder |
| 01/02/2004 | EP1374898A1 Remedies for nerve damages |
| 01/02/2004 | EP1374891A1 Method for accelerating the rate of mucociliary clearance |
| 01/02/2004 | EP1374890A2 Thrombopoietin compositions for increasing circulating platelets |
| 01/02/2004 | EP1374888A1 Remedies for arthritis deformans and remedies for rheumatoid arthritis |
| 01/02/2004 | EP1374887A1 Novel agents for ameliorating motor disorder |
| 01/02/2004 | EP1374886A2 Treatment of neuromuscular disorders and conditions with different botulinum serotype |
| 01/02/2004 | EP1374885A1 Use of at least one peptide of alpha-s2 casein with inhibiting activity of ACE for the preparation of medicaments and foodstuffs |
| 01/02/2004 | EP1374875A2 Pharmaceutical compositons comprising arsenic for the treatment of myelodysplastic syndrome |
| 01/02/2004 | EP1374854A1 Delayed release pharmaceutical composition, method of production and use of said composition |
| 01/02/2004 | EP1373905A2 Method for detecting chronic dementia diseases, and corresponding peptides and detection reagents |
| 01/02/2004 | EP1373900A2 Renal cell carcinoma tumor markers |
| 01/02/2004 | EP1373554A2 Modulators of bruton's tyronsine kinase, their identification and use |
| 01/02/2004 | EP1373551A2 Multiple determinants for metabolic phenotypes |
| 01/02/2004 | EP1373540A1 Polysubstituted polycarboxylic phosphoamide biopolymers, methods for their production and uses of compositions derived therefrom |
| 01/02/2004 | EP1373537A2 Viral vectors |
| 01/02/2004 | EP1373526A2 Therapeutic polypeptides, nucleic acids encoding same, and methodes of use |
| 01/02/2004 | EP1373518A2 Modification of organelle metabolism by a composition comprising unc-51-like kinases, roma1, or 2tm polypeptides and uses thereof for the preparation of a medicament for the treatment of metabolic disorders |
| 01/02/2004 | EP1373517A2 Human kinases |
| 01/02/2004 | EP1373516A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins and uses thereof |
| 01/02/2004 | EP1373515A2 Means for inhibiting proteolytical processing of parkin |
| 01/02/2004 | EP1373514A2 Phosphorylation modifications of apoptin |
| 01/02/2004 | EP1373513A2 Streptococcus pneumoniae proteins and nucleic acids |
| 01/02/2004 | EP1373511A2 Genes and proteins, and their uses |
| 01/02/2004 | EP1373510A2 Mutant allergens |
| 01/02/2004 | EP1373508A2 Human cytokine receptor |
| 01/02/2004 | EP1373507A2 Stress-responsive activator of p300 (strap) protein |
| 01/02/2004 | EP1373506A2 Yeast strain of saccharomyces cerevisiae with functional expression of a glut transporter |
| 01/02/2004 | EP1373504A2 Mammalian tribbles signaling pathways and methods and reagents related thereto |
| 01/02/2004 | EP1373503A2 Neurotrophic factors |
| 01/02/2004 | EP1373502A2 Dopaminergic neuronal survival-promoting factors and uses thereof |
| 01/02/2004 | EP1373501A2 Targeting molecules for adenoviral vectors |
| 01/02/2004 | EP1373499A2 Hin-1, a tumor suppressor gene |
| 01/02/2004 | EP1373496A1 Methods for identifying peptides which modulate a biological process |
| 01/02/2004 | EP1373493A1 Coagulation factor vii derivatives |
| 01/02/2004 | EP1373492A1 Alpha-galactosidase as food-grade genetic marker |
| 01/02/2004 | EP1373489A2 Human dual specificity protein phosphatase 7-like protein |
| 01/02/2004 | EP1373487A2 Regulation of human protein kinase-like protein |
| 01/02/2004 | EP1373485A2 Ikk2 variant, dino gene, lectin-like receptor gene, and proteins encoded thereby |
| 01/02/2004 | EP1373483A2 Mono- and diacylglycerol acyltransferases and methods of use thereof |
| 01/02/2004 | EP1373366A2 Multi-arm block copolymers as drug delivery vehicles |
| 01/02/2004 | EP1373319A2 Composition comprising il-22 inhibitors and use thereof for treating inflammatory disorders |
| 01/02/2004 | EP1373317A2 Nuclear hormone receptor ligand binding domains |
| 01/02/2004 | EP1373316A2 Nuclear hormone receptor ligand binding domain |
| 01/02/2004 | EP1373315A2 Nuclear hormone receptor ligand binding domain |
| 01/02/2004 | EP1373313A2 Proteins and nucleic acids encoding same |
| 01/02/2004 | EP1373312A1 Shellfish protein |
| 01/02/2004 | EP1373310A2 Staphylococcus aureus proteins and nucleic acids |
| 01/02/2004 | EP1373308A2 Multimerization of hiv-1 vif protein as a therapeutic target |
| 01/02/2004 | EP1373306A2 Cytoskeletion-associated proteins |
| 01/02/2004 | EP1373305A1 Process for producing trunkamide a compounds |
| 01/02/2004 | EP1373304A1 INTEGRIN ALPHA IIbBETA 3 ACTIVIVING PEPTIDES AND THEIR USE |
| 01/02/2004 | EP1373303A1 Novel peptide ligands of leukocyte integrins |
| 01/02/2004 | EP1373301A2 Reducing the immunogenicity of fusion proteins |
| 01/02/2004 | EP1373300A2 Novel use of a peptide class of compound for treating non neuropathic inflammatory pain |
| 01/02/2004 | EP1373299A2 Connective tissue growth factor-2 |
| 01/02/2004 | EP1373296A2 Proteins producing an altered immunogenic response and methods of making and using the same |
| 01/02/2004 | EP1373293A1 Steap-related protein |
| 01/02/2004 | EP1373291A2 Antisense modulation of recql4 expression |
| 01/02/2004 | EP1373240A2 Retinoid x receptor modulators |
| 01/02/2004 | EP1372740A2 Methods for using annexin for detecting cell death in vivo and treating associated conditions |
| 01/02/2004 | EP1372736A2 Anti-neovasculature preparations for cancer |
| 01/02/2004 | EP1372735A2 Conjugate of hydroxyalkyl starch and an active agent |